Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohort - Takeaways - MDSpire

Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohort

  • By

  • Eva Pappe

  • Hadis Darvishi

  • Thomas Sgarbossa

  • Jacopo Saccomano

  • Kaid Darwiche

  • Stefan Andreas

  • Stephan Eisenmann

  • Bernd Schmidt

  • Wolfgang Gesierich

  • Nicolas Dickgreber

  • Christian Geltner

  • Joachim Hans Ficker

  • Angelique Holland

  • Björn Schwick

  • Stephan Eggeling

  • Ralf Eberhardt

  • Christian Grah

  • Christoph Hünermann

  • Urte Sommerwerck

  • Andreas Fertl

  • Sylke Kurz

  • Peter Schramm

  • Dinah von Schöning

  • Leif Erik Sander

  • Martin Witzenrath

  • Ralf-Harto Hübner

  • February 13, 2026

  • 0 min

Share

  • 1

    Endoscopic lung volume reduction (ELVR) with endobronchial valves improves lung function and quality of life in severe COPD patients.

  • 2

    Peri-interventional antibiotic prophylaxis is commonly used during ELVR to prevent complications like pneumonia and acute exacerbations.

  • 3

    Current guidelines do not recommend routine antibiotic use for bronchoscopic procedures due to insufficient evidence of clinical benefit.

  • 4

    The study aims to evaluate the impact of different antibiotic prophylaxis strategies on complications and outcomes in COPD patients undergoing ELVR.

  • 5

    Data were collected from the LE-Registry, focusing on patients treated with one-way valves and assessing various clinical outcomes.

Original Source(s)

Related Content